Overview

LutrePulse Hypogonadotropic Hypogonadism

Status:
Completed

Trial end date:
2018-02-23

Target enrollment:

Participant gender:

Summary

To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo

Phase:

Phase 3

Details

Lead Sponsor:

Ferring Pharmaceuticals

Treatments:

Prolactin Release-Inhibiting Factors